Clinical Trial

Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT)

Study acronym: LIFT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to reduce HIV transmission risk among people who inject drugs (PWID) through a multilevel intervention known as LIFT. LIFT intervenes to build intragroup PWID support at the community-level to reduce overall drug use and stigma. LIFT also increases efficacy in navigating HIV services in the presence of structural stigma. Additionally, LIFT intervenes on abstinence-based drug use stigma at the health facility-level to improve clinic policy and staff interactions with clients. This is an implementation study to adapt and pilot a stigma reduction intervention with persons who inject drugs (PWID) in Kyrgyzstan. The intervention includes peer-led group sessions focused on stigma reduction and providing support to increase HIV prevention efficacy. The aim will be to adapt, refine, and pilot the intervention among PWID and methadone maintenance treatment (MMT) clinic staff. Participants will be randomized to the intervention or control arms.
Trial Details
NCT Number NCT07541131
Lead Sponsor University of California, San Diego
Collaborators: Johns Hopkins University, RTI International, National Institute on Drug Abuse (NIDA)
Conditions Stigma, Social, Drug Abuse Illicit, HIV (Human Immunodeficiency Virus)
Enrollment 80 participants
Start Date 2026-02-09
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-21